SequelSEC

Beyond Air, Inc. XAIR

Surgical & Medical Instruments & Apparatus · CIK 0001641631 · Fiscal year ends 0331

AnnualQuarterlyTTM
Revenue
$7.69M
Fiscal year ended 2026-06-30
Operating income
-$28.04M
Fiscal year ended 2026-06-30
Free cash flow
-$19.60M
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$15.50MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-09-30
Float per share$1.08Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue2.0×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity2.5×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-09-30, not today, and each multiple below it uses the figures for the fiscal year ending 2026-03-31 — the year that filing covered.

How this compares in its industry

Percentile among the Surgical & Medical Instruments & Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Gross margin3.3%5th
Revenue YoY growth107.3%93th
SBC / revenue68.8%89th
CapEx / revenue13.3%86th
Operating margin-378.2%15th
Net margin-433.0%15th
R&D / revenue133.4%83th
FCF margin-249.6%18th
Current ratio3.80x59th

Beyond Air, Inc. (XAIR) reported revenue of $7.69M and net income of -$33.49M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Beyond Air, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

Beyond Air, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$7.69M
Cost of revenue$7.37M
Gross profit$321.00K
Operating income-$28.04M
Net income-$33.49M
Research & development$9.11M
Weighted-average diluted sharesUnavailable
Pretax income-$34.41M
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrative$19.25M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

Beyond Air, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$5.51M
Total assets$32.89M
Current assets$22.85M
Total liabilities$30.05M
Current liabilities$6.91M
Total equity incl. NCI$2.84M
Temporary (mezzanine) equityUnavailable
Inventory$1.29M
Accounts receivable$1.14M
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$2.46M

Cash flow

Beyond Air, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$18.56M
Capital expenditures$1.04M
Investing cash flow-$3.79M
Financing cash flow$28.08M
Net change in cash$5.78M
Stock-based compensation$4.74M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$3.20M

Derived

Beyond Air, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow-$19.60M
Gross margin4.2%
Operating margin-364.8%
FCF margin-255.0%
SBC / revenue61.7%
Current ratio3.31x
Revenue YoY growth60.7%
Net margin-435.7%
R&D / revenue118.6%
CapEx / revenue13.5%
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open XAIR in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-13View SEC filing
10-K · Filed 2026-06-26View SEC filing
10-Q · Filed 2026-02-13View SEC filing
10-Q · Filed 2025-11-10View SEC filing
10-Q · Filed 2025-08-12View SEC filing
10-K · Filed 2025-06-20View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.